HUE055904T2 - 2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása - Google Patents
2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállításaInfo
- Publication number
- HUE055904T2 HUE055904T2 HUE18722948A HUE18722948A HUE055904T2 HU E055904 T2 HUE055904 T2 HU E055904T2 HU E18722948 A HUE18722948 A HU E18722948A HU E18722948 A HUE18722948 A HU E18722948A HU E055904 T2 HUE055904 T2 HU E055904T2
- Authority
- HU
- Hungary
- Prior art keywords
- triazol
- preparation
- benzoic acid
- acid derivatives
- derivatives
- Prior art date
Links
- UTENUPFWBIFKPW-UHFFFAOYSA-N 2-(triazol-2-yl)benzoic acid Chemical class OC(=O)C1=CC=CC=C1N1N=CC=N1 UTENUPFWBIFKPW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2017060451 | 2017-05-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE055904T2 true HUE055904T2 (hu) | 2021-12-28 |
Family
ID=62116854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE18722948A HUE055904T2 (hu) | 2017-05-03 | 2018-05-02 | 2-([1,2,3]triazol-2-il)-benzoesav-származékok elõállítása |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11124488B2 (hu) |
| EP (1) | EP3619199B1 (hu) |
| JP (1) | JP7182562B2 (hu) |
| KR (1) | KR102582197B1 (hu) |
| CN (1) | CN110612291B (hu) |
| CA (1) | CA3059394C (hu) |
| CY (1) | CY1124777T1 (hu) |
| DK (1) | DK3619199T3 (hu) |
| ES (1) | ES2892161T3 (hu) |
| HR (1) | HRP20211304T1 (hu) |
| HU (1) | HUE055904T2 (hu) |
| IL (1) | IL270274B (hu) |
| LT (1) | LT3619199T (hu) |
| MX (1) | MX2019012902A (hu) |
| PL (1) | PL3619199T3 (hu) |
| PT (1) | PT3619199T (hu) |
| RS (1) | RS62357B1 (hu) |
| SI (1) | SI3619199T1 (hu) |
| TW (1) | TWI756418B (hu) |
| WO (1) | WO2018202689A1 (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297234A (en) | 2020-04-19 | 2022-12-01 | Idorsia Pharmaceuticals Ltd | Medical use of daridorexant |
| TW202400149A (zh) | 2022-05-13 | 2024-01-01 | 瑞士商愛杜西亞製藥有限公司 | 經噻唑并芳基-甲基取代之環狀肼-n-甲醯胺衍生物 |
| CN118724879B (zh) * | 2023-12-19 | 2025-02-11 | 南京知和医药科技有限公司 | 一种氘代稠环化合物及其制备方法与用途 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101506199A (zh) | 2006-08-15 | 2009-08-12 | 埃科特莱茵药品有限公司 | 用作食欲素受体拮抗剂的氮杂环丁烷化合物 |
| CA2662612A1 (en) | 2006-09-29 | 2008-04-03 | Actelion Pharmaceuticals Ltd | 3-aza-bicyclo[3.1.0]hexane derivatives |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| CL2007003827A1 (es) | 2006-12-28 | 2008-09-26 | Actelion Pharmaceuticals Ltd | Compuestos derivados de n-(2-aza-biciclo(3.1.0)hex-3-ilmetil)amida; y su uso para prevenir o tratar la depresion, neurosis, esquizofrenia, ansiedad, adicciones, epilepsia, dolor, enfermedades cardiacas, entre otras. |
| DE602008002934D1 (de) | 2007-05-14 | 2010-11-18 | Actelion Pharmaceuticals Ltd | 2-cyclopropylthiazolderivate |
| WO2008150364A1 (en) | 2007-05-23 | 2008-12-11 | Merck & Co., Inc. | Cyclopropyl pyrrolidine orexin receptor antagonists |
| WO2011050202A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
| PL3093291T3 (pl) | 2009-10-23 | 2019-11-29 | Janssen Pharmaceutica Nv | Dipodstawione oktahydropirolo[3,4-c]pirole jako modulatory receptora oreksyny |
| WO2011050200A1 (en) | 2009-10-23 | 2011-04-28 | Janssen Pharmaceutica Nv | Fused heterocyclic compounds as orexin receptor modulators |
| CN103443094A (zh) | 2010-12-17 | 2013-12-11 | 大正制药株式会社 | 吡唑衍生物 |
| WO2012085852A1 (en) | 2010-12-22 | 2012-06-28 | Actelion Pharmaceuticals Ltd | 3,8-diaza-bicyclo[4.2.0]oct-8-yl amides |
| EP2680697B1 (en) | 2011-03-03 | 2018-01-10 | Merck Sharp & Dohme Corp. | Process for the preparation of an orexin receptor antagonist |
| WO2012145581A1 (en) | 2011-04-20 | 2012-10-26 | Janssen Pharmaceutica Nv | Disubstituted octahy-dropyrrolo [3,4-c] pyrroles as orexin receptor modulators |
| TW201315730A (zh) | 2011-07-05 | 2013-04-16 | 大正製藥股份有限公司 | 甲基哌啶衍生物 |
| WO2013050938A1 (en) * | 2011-10-04 | 2013-04-11 | Actelion Pharmaceuticals Ltd | 3,7-diazabicyclo[3.3.1]nonane and 9-oxa-3,7-diazabicyclo[3.3.1]nonane derivatives |
| EA024106B1 (ru) | 2011-11-08 | 2016-08-31 | Актелион Фармасьютиклз Лтд. | Производные 2-(1,2,3-триазол-2-ил)бензамида и 3-(1,2,3-триазол-2-ил)пиколинамида |
| US9441254B2 (en) | 2012-05-09 | 2016-09-13 | Merck Sharp & Dohme Corp. | Process for the preparation of an intermediate for an orexin receptor antagonist |
| BR112014030173B1 (pt) | 2012-06-04 | 2022-10-04 | Idorsia Pharmaceuticals Ltd | Composto derivado de benzimidazol-prolina, e, composição farmacêutica |
| JP2014015452A (ja) | 2012-06-15 | 2014-01-30 | Taisho Pharmaceutical Co Ltd | ピラゾール誘導体を含有する医薬 |
| KR102151288B1 (ko) * | 2012-10-10 | 2020-09-03 | 이도르시아 파마슈티컬스 리미티드 | [오르토 바이 (헤테로 )아릴]-[2-(메타 바이 (헤테로 )아릴)-피롤리딘-1-일]-메타논 유도체인 오렉신 수용체 안타고니스트 |
| KR20150130413A (ko) | 2013-03-12 | 2015-11-23 | 액테리온 파마슈티칼 리미티드 | 오렉신 수용체 길항제로서의 아제티딘 아미드 유도체 |
| TW201444849A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代的7-氮雜雙環類及其作為食慾激素受體調節劑之用途 |
| TW201444821A (zh) | 2013-03-13 | 2014-12-01 | Janssen Pharmaceutica Nv | 經取代之哌啶化合物及其作為食慾素受體調節劑之用途 |
| HUE035731T2 (hu) * | 2013-12-03 | 2018-05-28 | Idorsia Pharmaceuticals Ltd | (S)-(2-(6-klór-7-metil-1H-benzo[d]imidazol-2-il)-2-metilpirrolidin-1-il)(5-metoxi-2- (2H-l,2,3-triazol-2-il)fenil)metanon kristályos formája és alkalmazása orexin receptor antagonistaként |
| UA119151C2 (uk) | 2013-12-03 | 2019-05-10 | Ідорсія Фармасьютікалз Лтд | КРИСТАЛІЧНА СОЛЬОВА ФОРМА (S)-(2-(6-ХЛОР-7-МЕТИЛ-1H-БЕНЗО[d]ІМІДАЗОЛ-2-ІЛ)-2-МЕТИЛПІРОЛІДИН-1-ІЛ)(5-МЕТОКСИ-2-(2H-1,2,3-ТРИАЗОЛ-2-ІЛ)ФЕНІЛ)МЕТАНОНУ ЯК АНТАГОНІСТ ОРЕКСИНОВОГО РЕЦЕПТОРА |
| EA029725B1 (ru) | 2013-12-04 | 2018-05-31 | Идорсиа Фармасьютиклз Лтд | Применение производных бензимидазолпролина |
| TW201613891A (en) * | 2014-02-12 | 2016-04-16 | Eolas Therapeutics Inc | Substituted prolines / piperidines as orexin receptor antagonists |
| WO2016020403A1 (en) | 2014-08-04 | 2016-02-11 | Sandoz Ag | Preparation of a benzoic acid derivative and its use for the preparation of suvorexant |
| CN104649983B (zh) * | 2014-12-23 | 2018-01-23 | 广东东阳光药业有限公司 | 一种酸的制备方法 |
| EP3287454B1 (en) * | 2015-04-24 | 2020-09-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
-
2018
- 2018-05-02 MX MX2019012902A patent/MX2019012902A/es unknown
- 2018-05-02 JP JP2019559016A patent/JP7182562B2/ja active Active
- 2018-05-02 DK DK18722948.9T patent/DK3619199T3/da active
- 2018-05-02 HU HUE18722948A patent/HUE055904T2/hu unknown
- 2018-05-02 RS RS20211164A patent/RS62357B1/sr unknown
- 2018-05-02 CA CA3059394A patent/CA3059394C/en active Active
- 2018-05-02 LT LTEPPCT/EP2018/061172T patent/LT3619199T/lt unknown
- 2018-05-02 IL IL270274A patent/IL270274B/en unknown
- 2018-05-02 PL PL18722948T patent/PL3619199T3/pl unknown
- 2018-05-02 ES ES18722948T patent/ES2892161T3/es active Active
- 2018-05-02 PT PT18722948T patent/PT3619199T/pt unknown
- 2018-05-02 CN CN201880028762.9A patent/CN110612291B/zh active Active
- 2018-05-02 US US16/610,413 patent/US11124488B2/en active Active
- 2018-05-02 WO PCT/EP2018/061172 patent/WO2018202689A1/en unknown
- 2018-05-02 SI SI201830396T patent/SI3619199T1/sl unknown
- 2018-05-02 EP EP18722948.9A patent/EP3619199B1/en active Active
- 2018-05-02 TW TW107114814A patent/TWI756418B/zh active
- 2018-05-02 KR KR1020197035319A patent/KR102582197B1/ko active Active
-
2021
- 2021-08-12 HR HRP20211304TT patent/HRP20211304T1/hr unknown
- 2021-10-06 CY CY20211100871T patent/CY1124777T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3059394C (en) | 2023-09-12 |
| WO2018202689A1 (en) | 2018-11-08 |
| PT3619199T (pt) | 2021-10-01 |
| CN110612291A (zh) | 2019-12-24 |
| MX2019012902A (es) | 2019-12-16 |
| KR102582197B1 (ko) | 2023-09-22 |
| SI3619199T1 (sl) | 2021-11-30 |
| DK3619199T3 (da) | 2021-09-27 |
| TW201843144A (zh) | 2018-12-16 |
| PL3619199T3 (pl) | 2021-12-20 |
| CY1124777T1 (el) | 2022-11-25 |
| EP3619199B1 (en) | 2021-07-07 |
| IL270274A (hu) | 2019-12-31 |
| RS62357B1 (sr) | 2021-10-29 |
| JP7182562B2 (ja) | 2022-12-02 |
| US11124488B2 (en) | 2021-09-21 |
| TWI756418B (zh) | 2022-03-01 |
| KR20200003097A (ko) | 2020-01-08 |
| LT3619199T (lt) | 2021-09-27 |
| US20210114997A1 (en) | 2021-04-22 |
| CN110612291B (zh) | 2024-02-13 |
| IL270274B (en) | 2022-08-01 |
| JP2020518573A (ja) | 2020-06-25 |
| EP3619199A1 (en) | 2020-03-11 |
| HRP20211304T1 (hr) | 2021-11-12 |
| ES2892161T3 (es) | 2022-02-02 |
| CA3059394A1 (en) | 2018-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3402787A4 (en) | PROCESSES FOR PREPARING 2,5-FURANDICARBOXYLIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF | |
| HUE065368T2 (hu) | Eljárás 2,5-furándikabonsav és származékai elõállítására | |
| HK1254055A1 (zh) | 製備奧貝膽酸及其衍生物的方法 | |
| EP3679945A4 (en) | AQUEOUS PHARMACEUTICAL COMPOSITION | |
| IL271399A (en) | Methods for the preparation of heterocyclic 3,1-benzodioxole compounds | |
| EP3647305A4 (en) | PIPERIDIC ACID DERIVATIVE AND PRODUCTION AND APPLICATION THEREOF | |
| IL260011A (en) | History of 5,3-diphenyl-diazole water-soluble compounds | |
| EP3315492A4 (en) | Pyrazole derivative, or pharmaceutically acceptable salt thereof | |
| RS62357B1 (sr) | Dobijanje derivata 2-([1,2,3]triazol-2-il)-benzojeve kiseline | |
| EP3442943A4 (en) | AMINOBENZOIC ACID DERIVATIVES FOR USE AS ANTI-INFLAMMATORY AGENTS, ANTI-METASTATIC AGENTS AND / OR ANTICANCER AGENTS | |
| HK1256825A1 (zh) | 取代的5，6-二氫-6-苯基苯並[f]異喹啉-2-胺化合物的固體形式 | |
| MX2018007415A (es) | Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-ami na sustituida. | |
| IL262405A (en) | Methods for preparing obeticholic acid and its derivatives | |
| IL254578A0 (en) | Abscisic acid (s)-2' vinyl derivatives | |
| EP3189842A4 (en) | Composition for preventing hair loss or promoting hair growth, containing oleanolic acid derivative and pharmaceutically acceptable salt thereof | |
| HK1258757A1 (zh) | 4H-吡唑並[1，5-α]苯並咪唑類化合物的鹽型、晶型及其製備方法和中間體 | |
| SG11202003286YA (en) | Cool-sensation imparter composition containing 2,2,6-trimethylcyclohexanecarboxylic acid derivative | |
| IL259073A (en) | History of abscisic acid - converted at the 3' position | |
| EP3436439A4 (en) | METHOD FOR PRODUCING DIPHENYLPYRAZINE DERIVATIVES | |
| HUE059444T2 (hu) | Morfolinszármazék sója és ennek kristályformája, valamint ezek elõállítási eljárása, gyógyszerkészítménye és alkalmazása | |
| IL277066A (en) | History of LNA-dicarboxylic acid and process for their preparation | |
| EP3856732C0 (en) | METHOD AND SALTS FOR PRODUCING 2,5-FURANDICARBONIC ACID | |
| IL257438B (en) | An improved process for the preparation of tetraforsamine or its acid salt | |
| HUP1500451A2 (en) | Processes for the preparation of 1,4,7-triaza-cyclononane derivatives and intermediates |